Repurposing of Miltefosine as an Adjuvant for Influenza Vaccine
Lu Lu(Fudan University), Kelvin Kai‐Wang To(Hong Kong Science and Technology Parks Corporation), Lin‐Lei Chen(Queen Mary Hospital), Ivan Fan‐Ngai Hung(Chinese University of Hong Kong), Hin Chu(HKU-Pasteur Research Pole), Iris Can Li(University of Hong Kong), Jinxia Zhang(Peking University), Kwok‐Yung Yuen(University of Hong Kong - Shenzhen Hospital), Thrimendra Kaushika Dissanayake(University of Hong Kong), Andrew Chak-Yiu Lee(Hong Kong Science and Technology Parks Corporation), Kin‐Hang Kok(University of Hong Kong), Wai‐Lan Wu(University of Hong Kong), Kwok‐Hung Chan(University of Hong Kong), Carol Ho-Yan Fong(Chinese University of Hong Kong)
Cited by 8
Related Papers
A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster
|The Lancet|2020|9.6k
Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study
|The Lancet Infectious Diseases|2020|3.4k
Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan
|Emerging Microbes & Infections|2020|3.3k
Consistent Detection of 2019 Novel Coronavirus in Saliva
|Clinical Infectious Diseases|2020|2k
Coronaviruses — drug discovery and therapeutic options
|Nature Reviews Drug Discovery|2016|1.8k